Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • didipao
    Junior Member
    • Jul 2011
    • 8

    #16
    Originally posted by gringer View Post
    This is a good point. I just assumed didipao had access to the gene sequence from this statement:
    I know which gene the peptides come from. In some cases I sequenced 2 versions of the peptide: one corresponds to a canonical protein (100% blast) and the other version of the peptide differs by one single amino acid. For most cases I did not find any known SNP in dbSNP that corresponds to the variation I found in the peptide. So I suppose that either I have a new DNA mutation (I have to confirm by sequencing) or a "post-DNA" modification such as RNA editing....I also plan to sequence the RNA.

    In some cases I have 2 versions of the peptide, and the variation is reported in dbSNP. I still need to confirm by sequencing the DNA or other methods. So, I supposed that in such cases I can used the method suggested by gringer.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Yesterday, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    71 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...